Talking Point With Sheela Foam's MD Rahul Gautam

Higher input costs weigh on Sheela Foam's margins even as revenue and profit see an uptick in Q4. MD Rahul Gautam discusses outlook for FY22 with Niraj Shah. #BQLive
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.